Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-261-7 | CAS number: 4427-96-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 03 Sep to 12 Oct 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
- Report date:
- 2022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosomal Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- (4R)-4-ethenyl-1,3-dioxolan-2-one; (4S)-4-ethenyl-1,3-dioxolan-2-one
- EC Number:
- 700-261-7
- Cas Number:
- 4427-96-7
- Molecular formula:
- C5H6O3
- IUPAC Name:
- (4R)-4-ethenyl-1,3-dioxolan-2-one; (4S)-4-ethenyl-1,3-dioxolan-2-one
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- Batch No.: 10121040902
Purity: 99.92%
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster lung (CHL/IU)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9: Aroclor 1254 induced rat-liver S9
- method of preparation of S9 mix: The S9 was prepared from the livers of the rats induced with Aroclor1254, and the details were shown below: Male SD (Sprague-Dawley) rats were treated by a single intraperitoneal injection of Aroclor 1254 at the dose of 500 mg/kg body weight five days prior to the S9 preparation. The livers of the rats were taken out under aseptic conditions, homogenized in a 0.15 mol/L KCl solution (1g liver: 3ml KCl solution) and centrifuged at 11000rpm for 10 min with AllegraTM 64R Auto Freeze Centrifuge. The supernatant of S9 was stored in liquid nitrogen at approximate -196℃ for use not more than one year. - Test concentrations with justification for top dose:
- 6 doses of 2000, 800, 320, 128, 51.2 and 20.48 μg/ml
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The test results of test item solubility showed that the test item could be dissolved in DMSO at the concentration of 400mg/ml, so DMSO was used as solvent.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- Used as the positive control in the absence of S9 mix (S9-)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Cyclophosphamide monohydrate
- Remarks:
- Used as the positive control in the presence of S9 mix (S9+)
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration (single, duplicate, triplicate): duplicate
- Number of independent experiments: 1
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable): 2.0E+05 CHL cells
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Preincubation period, if applicable:
- Exposure duration/duration of treatment: 3h or 24h
- Harvest time after the end of treatment (sampling/recovery times): 23h
FOR CHROMOSOME ABERRATION:
Based on the results of cytotoxicity in each treatment condition, the cells of the doses of 2000, 800 and 320μg/ml exposed in the above three treatment conditions and all controls were chosen for chromosome preparation.
300 well-spread metaphase cells equally divided among the duplicates were scored per dose and control for each treatment condition. Different types of structural chromosome aberrations listed below were scored. Gaps were scored separately. Polyploidy and endoreduplication were scored at the same time. The number of centromeres equal to the modal number ± 2 should be met. - Evaluation criteria:
- Providing that all validity criteria are fulfilled in any of the treatment condition examined, when all of the following criteria are met, the result is considered to be clearly positive:
a) At least one of the test dose exhibits a statistically significant increase compared with the concurrent solvent control (P<0.05);
b) The increase is dose-related when evaluated with an appropriate trend test.
c) Any of the results is outside the 95% control limits of historical negative control data distribution in this lab.
Providing that all validity criteria are fulfilled in all of the treatment conditions examined, when all of the following criteria are met, the result is considered to be clearly negative:
a) None of the test dose exhibits a statistically significant increase compared with the concurrent negative control;
b) There is no dose-related increase when evaluated with an appropriate trend test. c) All results of the doses are inside the 95% control limits of historical negative control data distribution in this lab.
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster lung (CHL/IU)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The results of test item precipitate: In this test, no test item precipitate was observed at all designed dose levels at the beginning and end of the treatment in three treatment conditions.
The results for cytotoxicity: The RICC of the cells exposed for 3h in the absence of S9 mix at the doses of 2000, 800, 320, 128, 51.2 and 20.48μg/ml were 78%, 84%, 92%, 94%, 98% and 102%; the RICC of the cells exposed for 3h in the presence of S9 mix at the doses of 2000, 800, 320, 128, 51.2 and 20.48μg/ml were 83%, 95%, 91%, 94%, 102% and 100%; the RICC of the cells exposed for 24h in the absence of S9 mix at the doses of 2000, 800, 320, 128, 51.2 and 20.48μg/ml were 81%, 92%, 97%, 94%, 91% and 95%.
The results of the microscopic analysis: the percentage of cells with structural chromosomal aberration excluding gap exposed for 3h in the absence of S9 mix at the doses of 2000, 800 and 320μg/ml were 0.7%, 0.3% and 0.3%; the percentage of cells with structural chromosomal aberration excluding gap exposed for 3h in the presence of S9 mix at the doses of 2000, 800 and 320μg/ml were 0.7%, 0.3% and 0.3%; the percentage of cells with structural chromosomal aberration excluding gap exposed for 24h in the absence of S9 mix at the doses of 2000, 800 and 320μg/ml were 0.7%, 0.7% and 0.3%. No statistically significant difference was observed at all doses of each test condition as compared with the concurrent solvent control (P>0.05). At the same time, statistically significant increases were observed in the cells of all positive controls as compared with the concurrent solvent controls(P<0.01).
Applicant's summary and conclusion
- Conclusions:
- The results of chromosomal aberration test were negative in three treatment conditions. Thus the test item was considered not to cause structural chromosomal aberrations in cultured mammalian cells.
- Executive summary:
The study was performed to evaluate test item for its capability to cause structural chromosomal aberrations in cultured mammalian cells. Three treatment conditions were performed in this study including exposing to the test item for 3 hours with and without the metabolic activation, and for 24 hours without the metabolic activation. The method of this study was designed to be in compliance with the OECD Guideline 473.
In this study, the results of chromosomal aberration test were negative in three treatment conditions. Thus the test item, was considered not to cause structural chromosomal aberrations in cultured mammalian cells under the conditions of this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.